Latest News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Fanuc Corporation ( TSE:6954 ) shareholders are probably feeling a little disappointed, since its shares fell 6.7% to...

California BanCorp (BCAL) has just wrapped up FY 2025 with fourth quarter total revenue of US$50.3 million and basic EPS of US$0.51, while on a trailing twelve month basis revenue was US$189 million and EPS came in at US$1.95. Over the past year, the company has seen revenue move from US$105.7 million to US$189 million and EPS shift from US$0.22 to US$1.95 on a trailing basis, alongside a net profit margin that moved to 33.4% from 5.1%. This puts investor attention squarely on the quality and...

Key Insights SD Biosensor's significant public companies ownership suggests that the key decisions are influenced by...

Brookfield Asset Management reported strong quarterly results, signaling solid operating momentum. The company announced an acquisition of UK based Just Group, expanding further into the pension risk transfer and retirement market. Brookfield also introduced an AI infrastructure strategy that aims to use its existing capabilities in power, data centers, and real assets. TSX:BAM last closed at CA$69.67, with the share price showing a 79.2% return over the past 3 years and a 1 year return of...

NasdaqGS:NDAQ has amended its corporate charter to allow limited officer exculpation. The change became effective in January 2026 after approval by the US Securities and Exchange Commission. The update affects how Nasdaq's officers are legally protected in connection with corporate decisions. NasdaqGS:NDAQ operates one of the major US securities exchanges and a suite of market technology, data, and listing services used by issuers and investors worldwide. Governance decisions at the holding...

MSCI (MSCI) just posted its latest FY 2025 numbers with Q3 revenue of US$793.4 million and basic EPS of US$4.26, alongside a trailing twelve month net margin of 40% compared with 43.1% a year earlier. The company has seen quarterly revenue move from US$707.9 million in Q2 2024 to US$793.4 million in Q3 2025, while basic EPS has gone from US$3.37 to US$4.26 over the same stretch. This sets the backdrop for investors who are tracking how profit margins are holding up. Given the combination of...

ANYCOLOR (TSE:5032) has launched a new share buyback program, with Board approval to repurchase up to 1,250,000 shares, representing 2.05% of outstanding stock, for up to ¥5,000 million. See our latest analysis for ANYCOLOR. The buyback news lands after a choppy period for the share price, with a 2.04% 7-day share price return following a 30-day share price decline of 9.07% and a 90-day share price decline of 23.43%. Even so, longer-term momentum is still intact, with a 1-year total...

KinjiroLtd (TSE:4013) has had a rough month with its share price down 13%. However, a closer look at its sound...

Sysco (SYY) has put up another quarter of solid scale, with Q2 2026 revenue of about US$20.8b, basic EPS of US$0.81 and net income excluding extra items of US$389m, while the trailing twelve months show revenue of roughly US$82.6b, EPS of US$3.73 and net income of US$1.80b. Over the last six reported quarters, revenue has ranged between about US$19.6b and US$21.1b, while quarterly EPS has moved between roughly US$0.81 and US$1.10. This sets the backdrop for a story that hinges on how much...

CNB Financial (CCNE) just posted fourth quarter FY 2025 revenue of US$101.9 million and basic EPS of US$1.10, capping off a trailing twelve month run of US$273.3 million in revenue and US$2.50 in EPS that reflects 23.9% earnings growth over the past year. Over that same twelve month stretch, net income reached US$61.4 million, and the bank paired a 3.65% net interest margin with a 61.49% cost to income ratio. Taken together, these figures offer a clear view of how efficiently the bank is...

Key Insights The considerable ownership by individual investors in YG Entertainment indicates that they collectively...

Lennox International (LII) has put another solid quarter on the board for FY 2025, with Q3 revenue of US$1.4 billion, basic EPS of US$7.00 and net income of US$245.8 million setting the tone for this earnings season update. The company has seen quarterly revenue move from US$1.5 billion in Q2 2025 to US$1.4 billion in Q3, while EPS has shifted from US$7.86 to US$7.00 over the same stretch. This gives investors a clean read on how the top and bottom line are tracking through the year. With...

Madrigal Pharmaceuticals recently reported that its liver disease drug Rezdiffra has reached over US$1.00 billion in annualized sales, while also signing an exclusive global license agreement with Pfizer for ervogastat, a clinical-stage DGAT-2 inhibitor to expand its MASH treatment pipeline. This combination of rapid commercial uptake for Rezdiffra and external pipeline expansion with Pfizer highlights how Madrigal is trying to build a broader franchise in liver disease treatments. We’ll now...

When close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 14x, you may consider JT...

Otis Worldwide (OTIS) opened FY 2025 with third quarter revenue of US$3.7b and basic EPS of US$0.96, alongside trailing 12 month revenue of US$14.3b and EPS of US$3.41 that frame how the latest print fits into the year so far. The company has seen quarterly revenue move from US$3.6b in Q3 2024 to US$3.7b in Q3 2025, while basic EPS shifted from US$1.35 to US$0.96 over the same period. This sets up a picture where top line scale holds steady, and margins do more of the talking for...

Enova International's FY 2025 Earnings Snapshot Enova International (ENVA) has capped FY 2025 with fourth quarter revenue of US$412.9 million and basic EPS of US$3.19, while trailing twelve month EPS sits at US$12.25 on revenue of about US$1.5 billion. The company has seen quarterly revenue move from US$323.5 million in Q3 2024 to US$412.9 million in Q4 2025, with basic EPS over that stretch ranging from US$1.64 to just above US$3 per share. With net margin at 20.7% over the last year versus...

Genesem Inc.'s ( KOSDAQ:217190 ) price-to-earnings (or "P/E") ratio of 32.2x might make it look like a strong sell...

Starbucks (SBUX) opened fiscal Q1 2026 with revenue of US$9.9b and basic EPS of US$0.26, alongside net income of US$293.3m, setting the tone for how investors assess the latest quarter against a year of softer profitability. Over the past year, the company has seen quarterly revenue range from US$8.8b to US$9.6b and EPS move between US$0.12 and US$0.69, while trailing twelve month figures sit at US$37.7b of revenue, EPS of US$1.20 and net income of US$1.37b. With the trailing net margin at 5%...

John Marshall Bancorp (JMSB) just turned in another steady quarter for FY 2025, with Q3 revenue of about US$15.9 million and basic EPS of roughly US$0.38 on net income of US$5.4 million. The bank has seen revenue move from US$13.4 million and EPS of about US$0.30 in Q3 2024 to US$15.9 million and EPS of roughly US$0.38 in Q3 2025. Trailing 12 month EPS sits around US$1.41 on net income of about US$20.0 million, which highlights a story where higher earnings and firmer profitability metrics...

Taysha Gene Therapies recently reported progress in its TSHA-102 gene therapy program for Rett syndrome, including dosing the first patient in the pivotal REVEAL trial and securing FDA alignment on the study design, while senior executives disclosed significant insider stock sales. This combination of clinical and regulatory milestones with insider activity offers a rare window into both the program’s momentum and leadership’s capital decisions. We’ll now examine how the FDA’s alignment on...

NVR (NVR) has just posted its FY 2025 third quarter numbers, with revenue of US$2.6b and basic EPS of US$119.26, set against a trailing 12 month EPS of US$484.98 and revenue of US$10.6b. Over recent quarters, revenue has moved from US$2.6b in Q2 2025 and US$2.4b in Q1 2025, alongside basic EPS of US$114.52 and US$100.41 respectively. This gives investors a clear read on the run rate as they weigh the latest figures against a net profit margin that has eased from 15.9% to 13.5% over the past...

Orrstown Financial Services (ORRF) has rounded out FY 2025 with fourth quarter revenue of US$64.8 million and basic EPS of US$1.12, alongside trailing twelve month revenue of US$252.1 million and EPS of US$4.21. Over the last few quarters, revenue has moved from US$60.1 million in Q4 2024 to US$64.8 million in Q4 2025, while quarterly basic EPS has shifted from US$0.72 to US$1.12 over the same period. This frames a year in which trailing net income reached US$80.9 million. With a trailing net...

Key Insights HB SOLUTION's significant individual investors ownership suggests that the key decisions are influenced by...